| Company Name: |
TargetMol |
| Tel: |
400-821-0310 15002144251 |
| Email: |
xuexiang.shao@tsbiochem.com |
7-bromo-3-hydroxy-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one manufacturers
|
| | 7-bromo-3-hydroxy-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one Basic information |
| | 7-bromo-3-hydroxy-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one Chemical Properties |
| Melting point | 202-203 °C(Solv: ethanol (64-17-5)) | | Boiling point | 517.6±50.0 °C(Predicted) | | density | 1.61±0.1 g/cm3(Predicted) | | solubility | DMSO: Soluble: =10 mg/ml Ethanol: Slightly soluble: 0.1-1 mg/ml | | pka | 10.94±0.70(Predicted) |
| | 7-bromo-3-hydroxy-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one Usage And Synthesis |
| Uses | 3-Hydroxy desalkylgidazepam (compound 2) is the active metabolite of Gidazepam (HY-U00315) and Desalkylgidazepam (HY-W634748). | | References | [1] Pavlovsky V I, et al. Synthesis, Affinity for Central Benzodiazepine Receptors, and Hypnosedative and Anxiolytic Properties of 3-Acyloxy-5-Aryl-7-Bromo-1, 2-Dihydro-3 H-1, 4-Benzodiazepin-2-Ones[J]. Pharmaceutical Chemistry Journal, 2019, 53: 207-211. [2] PETER D MASKELL Kieran R M Gemma Wilson. Designer Benzodiazepines Gidazepam and Desalkygidazepam (Bromonordiazepam): What Do We Know[J]. Journal of analytical toxicology, 2023, 47 4: 324-331. DOI: 10.1093/jat/bkad004 [3] G B KOLYVANOV. [Gidazepam biotransformation and pharmacokinetics in different species of animals and man].[J]. Eksperimental”naya i Klinicheskaya Farmakologiya, 1993, 56 3: 48-50. [4] V. I. PAVLOVSKII. Synthesis and Analgesic Activity of 3-Arylamino-1,2-Dihydro-3H-1,4-Benzodiazepin-2-Ones[J]. Pharmaceutical Chemistry Journal, 2015, 32 1: 592-597. DOI: 10.1007/s11094-015-1335-4 |
| | 7-bromo-3-hydroxy-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one Preparation Products And Raw materials |
|